Compound Summary
Compound Name: | Sulfoxaflor |
Compound CID: | 16723172 |
Synonyms: | Sulfoxaflor 946578-00-3 Cyanamide,N-methyloxido1-6-(trifluoromethyl)-3-pyridinylethyl-l4-sulfanylidene- N-(methyloxido(1-(6-(trifluoromethyl)-3-pyridinyl)ethyl)-lambda4-sulfanylidene)cyanamide GF 2032; GF 2372; XDE 208 More... |
Iupac Name: | [methyl-oxo-[1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]-lambda6-sulfanylidene]cyanamide |
InChI: | InChI=1S/C10H10F3N3OS/c1-7(18(2,17)16-6-14)8-3-4-9(15-5-8)10(11,12)13/h3-5,7H,1-2H3 |
InChIKey: | ZVQOOHYFBIDMTQ-UHFFFAOYSA-N |
Canonical Smiles: | CC(C1=CN=C(C=C1)C(F)(F)F)S(=NC#N)(=O)C |
Isomeric Smiles: | CC(C1=CN=C(C=C1)C(F)(F)F)S(=NC#N)(=O)C |
Molecular Weight: | 277.27 |
Molecular Formula: | C10H10F3N3OS |
Molecular Weight: | 277.27 |
Molecular Formula: | C10H10F3N3OS |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 18 |
Complexity: | 459 |
Sulfoxaflor | Sulfoxaflor |
---|---|
Sulfoxaflor |
946578-00-3 |
Cyanamide,N-methyloxido1-6-(trifluoromethyl)-3-pyridinylethyl-l4-sulfanylidene- |
N-(methyloxido(1-(6-(trifluoromethyl)-3-pyridinyl)ethyl)-lambda4-sulfanylidene)cyanamide |
GF 2032; GF 2372; XDE 208 |
Transform |
sulfoxaflor A |
sulfoxaflor B |
Sulfoxaflor ISO |
methyl-oxo-1-6-(trifluoromethyl)pyridin-3-ylethyl-?^{6}-sulfanylidenecyanamide |
XDE 208 |
GF 2032 |
GF 2372 |
SCHEMBL520711 |
CHEMBL2230078 |
DTXSID0074687 |
HSDB 8245 |
CHEBI:133306 |
Methyl1-(2-trifluoromethylpyridin-5-yl)ethyl-N-cyanosulfoximine |
WMB57800 |
methyl-oxo-1-6-(trifluoromethyl)pyridin-3-ylethyl-lambda6-sulfanylidenecyanamide |
HY-118504 |
CS-0066179 |
Q14566721 |
methyl(oxido){1-6-(trifluoromethyl)pyridin-3-ylethyl}-lambda(6)-sulfanylidenecyanamide |
methyl(oxo){1-6-(trifluoromethyl)-3-pyridylethyl}-lambda6-sulfanylidenecyanamide |
N-(methyl(oxo)(1-(6-(trifluoromethyl)pyridin-3-yl)ethyl)-l6-sulfanylidene)cyanamide |
N-Methyl-oxo-1-6-(trifluoromethyl)-3-pyridylethyl-lambda6-sulfanylidenecyanamide |
Sulfoxaflor 100 microg/mL in Acetonitrile. Short expiry date due to chemical nature of component(s) |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apolygus lucorum | 1.230000000000000 | mg/L | 17.590000000000000 | 14.770000000000000 | -0.160000000000000 | NS | MALES | 32407334 | Inactive | ||||
Apolygus lucorum | 8.370000000000000 | mg/L | 17.480000000000000 | 24.120000000000000 | 0.380000000000000 | NS | MALES | 32407334 | Inactive | ||||
Apolygus lucorum | 1.230000000000000 | mg/L | 17.480000000000000 | 23.970000000000000 | 0.370000000000000 | S | MALES | 32407334 | Active | ||||
Apolygus lucorum | 8.370000000000000 | mg/L | 27.720000000000000 | 20.560000000000000 | -0.260000000000000 | S | FEMALES | 32407334 | Inactive | ||||
Apolygus lucorum | 8.370000000000000 | mg/L | 17.590000000000000 | 15.940000000000000 | -0.090000000000000 | NS | MALES | 32407334 | Inactive | ||||
Apolygus lucorum | 8.370000000000000 | mg/L | 21.470000000000000 | 18.970000000000000 | -0.120000000000000 | NS | FEMALES | 32407334 | Inactive | ||||
Apolygus lucorum | 1.230000000000000 | mg/L | 21.470000000000000 | 16.560000000000000 | -0.230000000000000 | NS | FEMALES | 32407334 | Inactive | ||||
Apolygus lucorum | 1.230000000000000 | mg/L | 27.720000000000000 | 27.520000000000000 | -0.010000000000000 | NS | FEMALES | 32407334 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Apolygus lucorum | 0.380000000000000 | 1 | 8 |